4.7 Article

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

Related references

Note: Only part of the references are listed.
Review Public, Environmental & Occupational Health

The Rotterdam Study: 2010 objectives and design update

Albert Hofman et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)

Article Endocrinology & Metabolism

Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes

JE Hokanson et al.

DIABETES (2006)

Article Medicine, General & Internal

Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue

T Ruge et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Multidisciplinary Sciences

Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes

L Juntti-Berggren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men

DM Waterworth et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)

Article Public, Environmental & Occupational Health

Fetal origins of adult disease:: strength of effects and biological basis

DJP Barker et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)

Article Endocrinology & Metabolism

Glucose metabolism in lean patients with mild type 2 diabetes mellitus:: Evidence for insulin-sensitive and insulin-resistant variants

DA Garcia-Estévez et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2002)

Article Endocrinology & Metabolism

Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes

HY Li et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)

Article Endocrinology & Metabolism

Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins

M Lehtovirta et al.

DIABETOLOGIA (2000)